期刊文献+

比格犬ERβ剪切异构体ERβ419沉默表达载体的构建及筛选

Construction and identification of ERβ419 gene silencing recombined vectors of beagle ERβ isoforms
下载PDF
导出
摘要 目的构建最有效的慢病毒介导RNAi干扰序列,未来将应用于比格犬ERβ419的未知生物学功能的探索。方法模拟比格犬ERβ419靶细胞筛选针对目的基因mRNA设计的最佳干扰序列实验,通过qRT-PCR和Western Blot技术筛选最佳沉默表达载体序列。结果qRT-PCR结果显示,ERβ419-shRNA1(P<0.01)和ERβ419-shRNA3(P<0.01)的差异表达极显著,Western Blot结果与qRT-PCR结果一致,ERβ419-shRNA3的干扰效果最佳。结论 ERβ419-shRNA3最有效地抑制了目的基因的表达,未来将应用于探索比格犬ERβ419未知生物学功能对比格犬生殖系统影响的研究,并进而预防和治疗比格犬繁殖机能障碍性疾病。 Objective To construct and identify retroviral-mediated short hairpin RNA (shRNA) expression vectors of ERβ419, and explore ERβ419 unknown biological function in beagles in future. Methods To screen out the most effective gene silencing sequence of beagle ERβ419 mRNA using qRT-PCR and Western Blot assays, imitate beagle estrogen target cells. Results qRT-PCR results showed, ERβ419-shRNA1 (P 〈 0. 01 ) and ERβ419-shRNA3 ( P 〈 0. 01 )differed significantly, Western Blot result as same as qRT-PCR,ERβ419-shRNA3 is the best choice. Conclusion Beagles ERβ419-shRNA3 retrain most effectively target gene repression. It is applied to explore ERβ419 unknown biological function in beagles reproductive system, and to prevent and treat beagles reproductive function diseases.
出处 《中国比较医学杂志》 CAS 2014年第11期10-14,共5页 Chinese Journal of Comparative Medicine
基金 国家自然科学基金资助项目(31372271)
关键词 比格犬ERβ419 稳定表达细胞系 基因沉默 Beagles ERβ419 Stable expression cell lines Gene silencing
  • 相关文献

参考文献15

  • 1Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen[J]. FASEB, 1996,10(5):615-624.
  • 2Turner RT, Riggs BL, Spelsberg TC. Skeletal effects of estrogen[J]. Endocr Rev,1994,15(3):275-300.
  • 3Gennari L, Becherini L, Falchetti A, et al. Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms [J]. J Stero id Biochem Mol Biol,2002, 81(1): 1-24.
  • 4Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression[J]. J Mammary Gland Biol Neoplasia, 1998, 3(1): 49-61.
  • 5di Leo A, Messa C, Cavallini A, et al. Estrogens and colorectal cancer[J]. Curr Drug Targets Immune Endocr Metabol Disord, 2001, 1(1): 1-12.
  • 6Pujol P, Rey JM, Nirde P, et al. Differential expression of estrogen receptor-alpha and-beta messenger RNAs as a potential marker of ovarian carcinogenesis[J]. Cancer Res, 1998, 58(23): 5367-5373.
  • 7CyrM, Calon F, Morissette M, et al. Estrogenic modulation of brain activity: implications for schizophreniaand Parkinsons disease [J]. J Psychiatry Neurosci,2002, 27(1): 12-27.
  • 8Brandenberger AW, Tee MK, Jaffe RB. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues[J]. J Clin Endocrinol Metab, 1998,83(3):1 025-1 028.
  • 9Huang WW, Yin Y, Bi Q, et al. Developmental diethylstilbestrol exposure alters genetic pathways of uterinecy to differentiation[J]. Mol Cell Endocrinol, 2005,19(3):669-682.
  • 10谭小宁,周知,谢小雷,罗志勇.雌激素受体信号通路在乳腺癌发生和治疗中的作用[J].生命科学,2011,23(10):969-974. 被引量:18

二级参考文献54

  • 1孙治君,周鑫,姚榛祥,管小琴,李圆圆.P-gp、nm23和p53联合检测判断乳腺癌预后的价值[J].中国普外基础与临床杂志,2005,12(3):244-248. 被引量:9
  • 2Maehle BO, Collett K, Tretli S, et al. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer [J]. APMIS, 2009; 117(9): 644-650.
  • 3Fox EM, Andrade J, Shupnik MA. Novel actions of estrogen to promote protiferation: integration of cytoplasmic and nuclear pathways [J]. Steroids, 2009;74(7): 622-627.
  • 4Hopp TA, Weiss HL, Parra IS, et al. Low levels of estrogen receptor β protein predict resistance to Tamoxifen therapy in breast cancer [J]. Clin Cancer Res, 2004; 10(22): 7490-7499.
  • 5Herynk MH, Fuqua SA. Estrogen receptors in resistance to hormone therapy [J]. Adv Exp Med Biol, 2007; 608: 130-143.
  • 6Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary [J]. Proc Natl Acad Sei, 1996; 93(12): 5925-5930.
  • 7Green CA, Peter MB, Speirs V, et al. The potential role of ER beta isoforms in the clinical management of breast cancer [J]. Histopathology, 2008; 53(4): 374-380.
  • 8Lazennec G. Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis [J]. Cancer Lett, 2006; 231(2): 151-157.
  • 9Chen L, Qiu J, Yang X, et al. Identification of a novel estrogen receptor beta1 binding partner, inhibitor of differentiation-1, and role of ERbetal in human breast cancer cells [J]. Cancer Lett, 2009; 278(2): 210-219.
  • 10Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta [J]. Mol Interv, 2003; 3(5): 281-292.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部